Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese
Clinical trial NCT05616013 · COMPLETED
Trial details
- NCT number
- NCT05616013
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-16
- Primary completion
- 2024-05-16
- Enrollment
- 507
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.